今日吃瓜
Tag - gsk
Subscribe
Digital
Print
November 12, 2026
Subscribe
Digital
Print
Cyberattacks
Consumption tax
Foreign community in Japan
Latest News
Home Delivery
JAPAN
Politics
Society
Crime & Legal
Science & Health
Explainer
History
WORLD
Politics
Crime & Legal
Science & Health
Society
ASIA PACIFIC
Politics
Crime & Legal
Science & Health
Society
BUSINESS
Companies
Economy
Markets
Tech
SPORTS
Sumo
Soccer
Baseball
Basketball
Tennis
Olympics
More sports
OPINION
Editorials
Commentary
Geoeconomic Briefing
Environment
CLIMATE CHANGE
Energy
SUSTAINABILITY
WILDLIFE
EARTH SCIENCE
LIFE
Travel
Digital
Food & Drink
Style & Design
Language
Lifestyle
CULTURE
Film
Books
Music
Art
TV & Streaming
Stage
Entertainment news
COMMUNITY
Voices
Issues
How-tos
Our Lives
My Account
My Bookmarks
Logout
Subscribe for more access
GSK
BUSINESS
/
Companies
Oct 31, 2023
Drugmakers are set to pay 23andMe millions to access consumer DNA
Under the new agreement, 23andMe will provide GSK with access to anonymized DNA data from customers who have agreed to share their information.
WORLD
/
Science & Health
May 4, 2023
First RSV vaccine caps 60-year search to stem pervasive lung illness
The U.S. Food and Drug Administration cleared GSK’s shot against respiratory syncytial virus on Wednesday. The product will go on sale in the coming weeks for older adults.
WORLD
/
Science & Health
Jul 14, 2022
Why the world’s first malaria shot won’t reach millions of children who need it
The world’s inability to fund more Mosquirix shots dismays many in Africa. Children on the continent account for the vast majority of the roughly 600,000 global malaria deaths every year.
WORLD
/
Science & Health
Feb 3, 2015
Liberia begins clinical trial for Ebola vaccines as outbreak ebbs
Liberia began a trial of experimental Ebola vaccines on Monday, involving thousands of volunteers as part of an effort to slow the spread of the deadly fever and prevent future outbreaks.
WORLD
/
Science & Health
Nov 27, 2014
Ebola vaccine from Glaxo passes early safety test
An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine.
WHAT’S TRENDING
Editors' Picks
Man arrested over operation of rogue cellular base station in Tokyo
Government betting on language app powered by anime and AI
Man arrested over theft of watch that was returned days later to Tokyo mall
Japan not immune to public backlash against data centers, experts say
Jensen Huang’s woes evoke sympathy and disbelief in his birthplace Taiwan
‘Godzilla Minus Zero’ makes monster debut at the box office
A toast to Naohiko Noguchi, sake’s first living national treasure
Few signs of thaw in Japan-China relations one year after Takaichi’s Taiwan remarks
Mariko Mori predicted the future. She’ll do it again.
A legend reborn: ‘Ocarina of Time’ remake improves on the Zelda masterpiece
Podcast
Kabukicho: Tokyo’s ‘stadium of desire’
Longform
Convenience stores, toilets and the allure of everyday Japan
By
Elizabeth Beattie
SUSTAINABLE JAPAN
SPECIAL SUPPLEMENTS
Sponsored contents planned and edited by JT Media Enterprise Division.
SUPPLEMENTS BINDER